Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes
Recommendations
As issued by the authors
How to identify appropriate candidates for hybrid closed-loop (HCL) therapy in pregnancy
How to counsel pregnant women with diabetes on the potential risks and benefits of HCL therapy during pregnancy
How to manage commercially available systems off-label throughout gestation in an assisted HCL approach
Original publication
Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes. Diabetes Technol Ther. Published 1 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →